Integrating AI, Chemistry & Biology to Accelerate Macrocyclic Peptide Discovery

9:00 am - Wednesday 2nd December 2026

  • Explore how AI-driven co-folding approaches are enabling the rational design of synthetic macrocyclic peptides against challenging therapeutic targets.
  • Discover how integrating computational modelling with medicinal chemistry and experimental biology can improve hit quality, accelerate optimisation, and strengthen confidence in candidate selection.
  • Gain insights into building multidisciplinary discovery workflows that leverage AI to unlock next-generation macrocyclic peptide therapeutics.

Speakers:

Chief Executive Officer
Orbis Medicines